These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17602755)
1. Elevated anti-sulfatide antibodies in Guillain-Barré syndrome in T cell depleted at end-stage AIDS. Souayah N; Mian NF; Gu Y; Ilyas AA J Neuroimmunol; 2007 Aug; 188(1-2):143-5. PubMed ID: 17602755 [TBL] [Abstract][Full Text] [Related]
2. [A case with hepatitis A-associated Guillain-Barre syndrome and elevated serum anti-sulfatide antibody]. Obara D; Nagane Y; Utsugisawa K; Kondoh R; Tohgi H Rinsho Shinkeigaku; 2003; 43(1-2):38-40. PubMed ID: 12820550 [TBL] [Abstract][Full Text] [Related]
3. Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndrome. Gisslén M; Fredman P; Fuchs D; Lekman A; Rosengren L Scand J Infect Dis; 2005; 37(11-12):877-81. PubMed ID: 16308224 [TBL] [Abstract][Full Text] [Related]
4. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome. Chi LJ; Wang HB; Zhang Y; Wang WZ J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492 [TBL] [Abstract][Full Text] [Related]
5. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome. Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484 [TBL] [Abstract][Full Text] [Related]
6. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898 [TBL] [Abstract][Full Text] [Related]
7. Concurrent Guillain-Barré syndrome and myasthenia gravis: the first case in Taiwan. Kung SL; Su JM; Tsai SJ; Lu TM; Chen CM Acta Neurol Taiwan; 2009 Sep; 18(3):193-7. PubMed ID: 19960963 [TBL] [Abstract][Full Text] [Related]
8. [The treatment effect of immunoglobulin in AIDS with Guillain-Barre syndrome]. Zhang WL; Cao YA; Xia J; Yang L; Xie WX; Wang Y; Peng CS Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Jun; 27(3):210-1. PubMed ID: 24319960 [TBL] [Abstract][Full Text] [Related]
9. Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barré syndrome patients compared to controls. Harness J; McCombe PA J Clin Neurosci; 2008 Sep; 15(9):1031-5. PubMed ID: 18653346 [TBL] [Abstract][Full Text] [Related]
10. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091 [TBL] [Abstract][Full Text] [Related]
12. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies. Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534 [TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome during treatment with interferon alpha for hepatitis B. Boz C; Ozmenoglu M; Aktoz G; Velioglu S; Alioglu Z J Clin Neurosci; 2004 Jun; 11(5):523-5. PubMed ID: 15177399 [TBL] [Abstract][Full Text] [Related]
14. Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barré syndrome. Huang S; Li L; Liang S; Wang W J Neuroimmunol; 2009 Dec; 217(1-2):80-4. PubMed ID: 19853929 [TBL] [Abstract][Full Text] [Related]
15. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome. Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003 [TBL] [Abstract][Full Text] [Related]